Biotech Investors & VC Firms in Stockholm
15 firms in this list, with a median first check of $1.1M. 5 of them lead rounds. Generated from verified public data and updated continuously.
Industrifonden
StockholmPre-Seed–Series A$1.1M – $4.3M
38 people
Procuritas
StockholmGrowth
32 people
HealthCap
StockholmSeed–Growth
34 people
Sciety
StockholmSeed–Growth
21 people
Kinnevik
StockholmSeed–Late Stage
2 people
EIR Ventures
StockholmSeed–Growth
10 people
Curitas Ventures
StockholmSeed–Series B
5 people
Navigare Ventures
StockholmSeed–Growth
1 person
Sommet AB
StockholmPre-Seed–Growth
1 person
Leksell Social Ventures
StockholmPre-Seed–Series A$1M
2 people
MedCap AB
StockholmSeed–Series A
3 people
First Venture
StockholmSeed–Growth
1 person
SEB Greentech Venture Capital
StockholmSeed–Growth$1.1M – $4.3M
4 people
LSP (Life Sciences Partners)
AmsterdamSeries A–Late Stage$10.8M – $64.8M
41 people
Nordic Capital
Frankfurt am MainGrowth–Late Stage
12 people
Frequently asked questions
- Who are the top biotech investors & vc firms in stockholm?
- Top biotech investors & vc firms in stockholm include Industrifonden, Procuritas, HealthCap, Sciety, Kinnevik, EIR Ventures, Curitas Ventures, Navigare Ventures — 15 firms in total meet the criteria.
- What is the typical first check among biotech investors & vc firms in stockholm?
- The median first check among the 15 biotech investors & vc firms in stockholm tracked here is $1.1M.
- How many biotech investors & vc firms in stockholm lead rounds?
- 5 of the 15 biotech investors & vc firms in stockholm tracked here lead investment rounds.
Related lists
Investors & VC Firms in North America (14143)Investors & VC Firms in United States (13281)Investors & VC Firms in Europe (5575)Crypto & Web3 Investors & VC Firms (4830)Investors & VC Firms in Global (4158)SaaS Investors & VC Firms (3865)AI & Machine Learning Investors & VC Firms (3769)Fintech Investors & VC Firms (3726)Investors & VC Firms in Asia-Pacific (3574)Healthtech Investors & VC Firms (3415)
Data sourced from public filings and firms' own websites — see our methodology.












































